Asia Pacific Skin Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Melanoma and Non-Melanoma) and Screening Type (Blood Tests, Dermatoscopy, Imaging Tests, Lymph Node Biopsy, and Skin Biopsy)
The Asia Pacific skin cancer diagnostics market is expected to grow from US$ 660.1 million in 2021 to US$ 1,197.4 million by 2028; it is estimated to grow at a CAGR of 8.9% from 2021 to 2028.
Uncertainties in climatic conditions and the increasing exposure to ultraviolet radiation are unusual factors that trigger skin cancer incidence in various countries. However, mortality due to skin cancer is reducing in the region due to the continuously growing awareness regarding skin cancer. Also, increasing access to self-examination and screening tests simplifies the detection of skin cancer among people. The surge in awareness is primarily attributed to the support provided by various governments through awareness and prevention campaigns. The Centers for Disease Control and Prevention (CDC) and its partners conduct monitoring of skin cancer cases, their research, provide education, and interventions for skin cancer. The monitoring is achieved through national surveys, such as the Youth Risk Behavior Surveillance System and National Health Interview Survey. These surveys assist in assessing the prevalence of sunburn and sun-protective behaviors to help prevent skin cancer. Thus, governments’ efforts to control mortalities associated with skin cancer will likely provide significant opportunities to the Asia Pacific skin cancer diagnostics market players in the coming years.
With the new features and technologies, vendors attract new customers and expand their footprints in emerging markets. This factor is driving the growth of Asia Pacific skin cancer diagnostics market at a promising CAGR.
Asia Pacific Skin Cancer Diagnostics Market Revenue And Forecast To 2028 (US$ Million)
Get more information on this report :
Skin cancer diagnostics market is segmented into type and screening type. Based on type, the market is segmented into melanoma and non-melanoma. Based on screening type, the market is segmented into skin biopsy, dermatoscopy, lymph node biopsy, imaging tests, and blood tests. Based on country, the market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific.
AMLo Biosciences Limited; DermLite LLC; bioMerieux SA; Hoffmann-La Roche Ltd.; and Michelson Diagnostics Ltd. are among the leading companies in the Asia Pacific skin cancer diagnostics market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Skin Cancer Diagnostics Market – By Type
1.3.2 Asia Pacific Skin Cancer Diagnostics Market – By Screening Type
1.3.3 Asia Pacific Skin Cancer Diagnostics Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Skin Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific– PEST Analysis
4.3 Expert Opinion
5. Skin Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidence of Skin Cancer
5.1.2 Launch of New Skin Cancer Diagnostics Products
5.2 Market Restraints
5.2.1 Barriers to Early Skin Cancer Diagnostics in Low and Middle-Income Countries
5.3 Market Opportunities
5.3.1 Government Support for Early Skin Cancer Diagnosis
5.4 Future Trends
5.4.1 Skin Cancer Diagnostics Through AI
5.5 Impact Analysis
6. Skin Cancer Diagnostics Market – Asia Pacific Analysis
6.1 Asia Pacific Skin Cancer Diagnostics Market Revenue Forecast and Analysis
7. Skin Cancer Diagnostics Market Analysis – By Type
7.1 Overview
7.2 Skin Cancer Diagnostics Market Revenue Share, by Type (2020 and 2028)
7.3 Melanoma
7.3.1 Overview
7.3.2 Melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Non-melanoma
7.4.1 Overview
7.4.2 Non-melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Skin Cancer Diagnostics Market – By Screening Type
8.1 Overview
8.2 Skin Cancer Diagnostics Market, by Screening Type, 2020 and 2028 (%)
8.3 Blood Tests
8.3.1 Overview
8.3.2 Blood Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Dermatoscopy
8.4.1 Overview
8.4.2 Dermatoscopy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Imaging Tests
8.5.1 Overview
8.5.2 Imaging Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Lymph Node Biopsy
8.6.1 Overview
8.6.2 Lymph Node Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Skin Biopsy
8.7.1 Overview
8.7.2 Skin Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Skin Cancer Diagnostics Market – Regional Analysis
9.1 Asia Pacific Skin Cancer Diagnostics Market Revenue and Forecasts To 2028
9.1.1 Overview
9.1.2 Asia-Pacific: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3 Asia-Pacific: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.1.4 Asia-Pacific: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.1.5 Asia-Pacific: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
9.1.5.1 China: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 Overview
9.1.5.1.2 China: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ MILLION)
9.1.5.1.3 China: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.1.5.1.4 China: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.1.5.2 Japan: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ MILLION)
9.1.5.2.1 Overview
9.1.5.2.2 Japan: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.3 Japan: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.1.5.2.4 Japan: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.1.5.3 India: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 Overview
9.1.5.3.2 India: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.3 India: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.1.5.3.4 India: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.1.5.4 South Korea: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.4.1 Overview
9.1.5.4.2 South Korea: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.4.3 South Korea: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.1.5.4.4 South Korea: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.1.5.5 Australia: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.5.1 Overview
9.1.5.5.2 Australia: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.5.3 Australia: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.1.5.5.4 Australia: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
9.1.5.6 Rest of Asia-Pacific: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.6.1 Overview
9.1.5.6.2 Rest of Asia-Pacific: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.5.6.3 Rest of Asia-Pacific: Skin Cancer Diagnostics Market, by Type- 2019–2028 (US$ Million)
9.1.5.6.4 Rest of Asia-Pacific: Skin Cancer Diagnostics Market, by Screening Type- 2019–2028 (US$ Million)
10. Skin Cancer Diagnostic Market–Industry Landscape
10.1 Overview
10.2 Growth Strategies in the Skin Cancer Diagnostic Market (%)
10.3 Organic Developments
10.3.1 Overview
10.4 Inorganic Developments
10.4.1 Overview
11. Company Profiles
11.1 AMLo Biosciences Limited
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 SWOT Analysis
11.1.5 Key Developments
11.2 DermLite LLC
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 bioMerieux SA
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 HOFFMANN-LA ROCHE LTD.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.5 Michelson Diagnostics Ltd.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia-Pacific Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. Asia-Pacific Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 3. China Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 4. China Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 5. Japan Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 6. Japan Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 7. India Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. India Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 9. South Korea Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 10. South Korea Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 11. Australia Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 12. Australia Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of Asia-Pacific Skin Cancer Diagnostics Market, by Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of Asia-Pacific Skin Cancer Diagnostics Market, by Screening Type– Revenue and Forecast to 2028 (US$ Million)
Table 15. Organic Developments in the Skin Cancer Diagnostic Market
Table 16. Inorganic Developments in the Skin Cancer Diagnostics Market
Table 17. Glossary of Terms, Skin Cancer Diagnostics Market
LIST OF FIGURES
Figure 1. Skin Cancer Diagnostics Market Segmentation
Figure 2. Asia Pacific Skin Cancer Diagnostics Market Overview
Figure 3. Non-Melanoma Segment Held Largest Share of Type Segment in Skin Cancer Diagnostics Market
Figure 4. Australia is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Asia Pacific Skin Cancer Diagnostics Market, Industry Landscape
Figure 6. Asia Pacific PEST Analysis
Figure 7. Skin Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 8. Asia Pacific Skin Cancer Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 9. Skin Cancer Diagnostics Market Revenue Share, by Type (2020 and 2028)
Figure 10. Melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Non-melanoma: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Skin Cancer Diagnostics Market, by Screening Type, 2020 and 2028 (%)
Figure 13. Blood Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Dermatoscopy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Imaging Tests: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Lymph Node Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Skin Biopsy: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Asia-Pacific: Skin Cancer Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)
Figure 19. Asia-Pacific Skin Cancer Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Figure 20. Asia-Pacific: Skin Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 21. China: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ MILLION)
Figure 22. Japan: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. India: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. South Korea: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Australia: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Rest of Asia-Pacific: Skin Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Growth Strategies in the Skin Cancer Diagnostic Market (%)
- AMLo Biosciences Limited
- DermLite LLC
- F. HOFFMANN-LA ROCHE LTD
- bioMerieux SA
- Michelson Diagnostics Ltd.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific skin care diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific skin care diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.